Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4I055
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.595 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.667 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.571 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.643 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.319 |
CLV_PCSK_PC1ET2_1 | 39 | 41 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.563 |
DOC_MAPK_gen_1 | 91 | 100 | PF00069 | 0.343 |
DOC_MAPK_MEF2A_6 | 91 | 100 | PF00069 | 0.390 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.685 |
LIG_14-3-3_CanoR_1 | 104 | 110 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 143 | 149 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.398 |
LIG_Actin_WH2_2 | 173 | 190 | PF00022 | 0.319 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.610 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.410 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.434 |
LIG_LIR_Nem_3 | 193 | 197 | PF02991 | 0.597 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.281 |
LIG_RPA_C_Fungi | 139 | 151 | PF08784 | 0.509 |
LIG_SH2_SRC | 63 | 66 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.370 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.483 |
MOD_CK1_1 | 154 | 160 | PF00069 | 0.550 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.665 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.591 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.502 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.577 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.626 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.366 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.525 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.618 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.506 |
MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.491 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.443 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.469 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.496 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.504 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.554 |
MOD_PK_1 | 144 | 150 | PF00069 | 0.515 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.489 |
MOD_PKB_1 | 142 | 150 | PF00069 | 0.442 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.504 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.509 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.604 |
MOD_SUMO_for_1 | 98 | 101 | PF00179 | 0.465 |
TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.506 |
TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 141 | 144 | PF00400 | 0.584 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJU2 | Leptomonas seymouri | 51% | 100% |
A0A1X0NGY8 | Trypanosomatidae | 25% | 100% |
A0A3S7WXJ0 | Leishmania donovani | 100% | 100% |
A4HCN1 | Leishmania braziliensis | 76% | 100% |
E9AW18 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QBF8 | Leishmania major | 92% | 100% |
V5B4L7 | Trypanosoma cruzi | 33% | 95% |